194490-22-7

Usage

Uses

Used in Organic Synthesis:
3-Cyano-7-methylindole is utilized as a building block in the synthesis of various organic molecules. Its unique structure allows for the creation of a wide array of chemical entities, making it a valuable component in organic chemistry.
Used as a Fluorescent Probe in Bioimaging Studies:
3-CYANO-7-METHYLINDOLE serves as a fluorescent probe due to its interesting optical properties. It is used in bioimaging studies to visualize and track specific biological processes or structures within living organisms, contributing to advancements in life sciences research.
Used in Pharmaceutical Development:
3-Cyano-7-methylindole is recognized for its potential as a pharmaceutical intermediate. It plays a crucial role in the development of new drugs that target a variety of diseases and conditions, showcasing its versatility and importance in the pharmaceutical industry.

InChI:InChI=1/C10H8N2/c1-7-3-2-4-9-8(5-11)6-12-10(7)9/h2-4,6,12H,1H3

Upstream product

• 933-67-5 7-methyl-1H-indole 
• 135205-66-2 N?cyanosuccinimide 

Relevant academic research and scientific papers

GaCl3-Catalyzed C-H Cyanation of Indoles with N-Cyanosuccinimide

An efficient GaCl3-catalyzed direct cyanation of indoles and pyrroles using bench-stable electrophilic cyanating agent N-cyanosuccinimide was achieved and afforded 3-cyanoindoles and 2-cyanopyrroles in good yields and excellent regioselectivities. Notably, this protocol exhibited high reactivity for unprotected indoles and was applicable to a broad range of indole and pyrrole substrates.

NITROGENATED HETEROCYCLIC COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME

The present invention relates to novel compounds having a xanthine oxidase inhibitory effect and an uricosuric effect and pharmaceutical compositions comprising the same as an active ingredient. That is, the present invention relates nitrogen-containing heterocyclic compounds represented by the following general formula (I): wherein Y1 represents N or C(R4) ; Y2 represents N or C(R5) ; R4 and R5 independently represent an alkyl group, a hydrogen atom etc. ; one of R1 and R2 represents an optionally substituted aryl group, an alkoxygroup or an optionally substituted heterocyclic group; the other of R1 and R2 represents a haloalkyl group, a cyanogroup, ahalogenatometc.; and R3 represents a 5-tetrazolyl group or a carboxy group, and pharmaceutically acceptable salts thereof, and pharmaceutical compositions comprising the same as an active ingredient.